FDA Releases Raw Heparin Shipments To Amphastar
The U.S. Food and Drug Administration has agreed to release two shipments of raw heparin from China to Amphastar Pharmaceuticals Inc. amid the generic-drug maker's claims that the agency unlawfully detained...To view the full article, register now.
Already a subscriber? Click here to view full article